tradingkey.logo
tradingkey.logo
Search

Embecta Corp

EMBC
Add to Watchlist
3.140USD
0.0000.00%
Close 05/15, 16:00ETQuotes delayed by 15 min
186.29MMarket Cap
1.64P/E TTM

More Details of Embecta Corp Company

Embecta Corp. is a global medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. The Company has a portfolio of marketed products, including a variety of pen needles, syringes and safety injection devices. Its pen needles are sterile, single-use, medical devices, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. It also sells safety pen needles, which have shields on both ends of the cannula that automatically deploy after the injection to help prevent needlestick exposure and injury during injection and disposal. Its traditional and safety pen needles are compatible and frequently used with pen injectors in the market. It sells sterile, single-use insulin syringes, which are used to inject insulin drawn from insulin vials. It also sells safety insulin syringes. It distributes its products through a variety of channels, including retail, hospitals and pharmacies.

Embecta Corp Info

Ticker SymbolEMBC
Company nameEmbecta Corp
IPO dateMar 21, 2022
CEOKurdikar (Devdatt)
Number of employees1850
Security typeOrdinary Share
Fiscal year-endMar 21
Address300 Kimball Drive
CityPARSIPPANY
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code07054
Phone18624010000
Websitehttps://www.embecta.com/
Ticker SymbolEMBC
IPO dateMar 21, 2022
CEOKurdikar (Devdatt)

Company Executives of Embecta Corp

Name
Name/Position
Position
Shareholding
Change
Mr. Devdatt (Dev) Kurdikar
Mr. Devdatt (Dev) Kurdikar
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
291.24K
+2.14%
Mr. Jacob (Jake) Elguicze
Mr. Jacob (Jake) Elguicze
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
114.14K
-2.21%
Mr. Jeffrey Z. (Jeff) Mann
Mr. Jeffrey Z. (Jeff) Mann
Senior Vice President, General Counsel, Product Development
Senior Vice President, General Counsel, Product Development
95.43K
-0.06%
Mr. Christopher R. (Chris) Reidy
Mr. Christopher R. (Chris) Reidy
Director
Director
55.24K
+41.35%
Mr. Robert J. (Bob) Hombach, CPA
Mr. Robert J. (Bob) Hombach, CPA
Independent Director
Independent Director
49.70K
+45.95%
Ms. Carrie L. Anderson
Ms. Carrie L. Anderson
Independent Director
Independent Director
49.70K
+45.96%
Dr. Milton Mayo Morris, Ph.D.
Dr. Milton Mayo Morris, Ph.D.
Independent Director
Independent Director
45.58K
+50.12%
Mr. Shaun Curtis
Mr. Shaun Curtis
Senior Vice President - Global Manufacturing, Supply Chain and Quality
Senior Vice President - Global Manufacturing, Supply Chain and Quality
34.01K
-18.45%
Ms. Jean Casner
Ms. Jean Casner
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
20.34K
-83.88%
Dr. Claire Pomeroy, M.D.
Dr. Claire Pomeroy, M.D.
Lead Independent Director
Lead Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Devdatt (Dev) Kurdikar
Mr. Devdatt (Dev) Kurdikar
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
291.24K
+2.14%
Mr. Jacob (Jake) Elguicze
Mr. Jacob (Jake) Elguicze
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
114.14K
-2.21%
Mr. Jeffrey Z. (Jeff) Mann
Mr. Jeffrey Z. (Jeff) Mann
Senior Vice President, General Counsel, Product Development
Senior Vice President, General Counsel, Product Development
95.43K
-0.06%
Mr. Christopher R. (Chris) Reidy
Mr. Christopher R. (Chris) Reidy
Director
Director
55.24K
+41.35%
Mr. Robert J. (Bob) Hombach, CPA
Mr. Robert J. (Bob) Hombach, CPA
Independent Director
Independent Director
49.70K
+45.95%
Ms. Carrie L. Anderson
Ms. Carrie L. Anderson
Independent Director
Independent Director
49.70K
+45.96%

Revenue Breakdown

Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Pen Needles
185.50M
71.02%
Safety
37.30M
14.28%
Syringes
30.70M
11.75%
Manufacturing Facility
4.10M
1.57%
Other
3.60M
1.38%
By RegionUSD
Name
Revenue
Proportion
United States
130.90M
50.11%
International
130.30M
49.89%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Pen Needles
185.50M
71.02%
Safety
37.30M
14.28%
Syringes
30.70M
11.75%
Manufacturing Facility
4.10M
1.57%
Other
3.60M
1.38%

Shareholding Stats

Updated: Wed, May 13
Updated: Wed, May 13
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
13.63%
Yacktman Asset Management LP
6.19%
River Road Asset Management, LLC
5.81%
American Century Investment Management, Inc.
5.80%
Deerfield Management Company, L.P.
4.64%
Other
63.94%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
13.63%
Yacktman Asset Management LP
6.19%
River Road Asset Management, LLC
5.81%
American Century Investment Management, Inc.
5.80%
Deerfield Management Company, L.P.
4.64%
Other
63.94%
Shareholder Types
Shareholders
Proportion
Investment Advisor
45.29%
Investment Advisor/Hedge Fund
34.09%
Hedge Fund
10.48%
Research Firm
8.12%
Individual Investor
1.68%
Pension Fund
1.25%
Bank and Trust
0.71%
Family Office
0.61%
Venture Capital
0.03%

Institutional Shareholding

Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
791
59.40M
100.13%
-4.64M
2025Q4
771
58.75M
107.09%
-8.51K
2025Q3
810
58.76M
110.40%
-1.03M
2025Q2
820
59.48M
109.25%
+307.16K
2025Q1
855
59.15M
106.14%
-2.75M
2024Q4
884
57.08M
105.66%
+385.73K
2024Q3
903
56.12M
114.14%
-1.32M
2024Q2
966
57.37M
112.89%
+262.03K
2024Q1
996
57.10M
113.18%
-8.07M
2023Q4
1007
56.71M
107.91%
+769.57K
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
8.08M
13.65%
+194.55K
+2.47%
Dec 31, 2025
Yacktman Asset Management LP
2.26M
3.82%
+71.21K
+3.25%
Dec 31, 2025
River Road Asset Management, LLC
3.42M
5.77%
+171.19K
+5.28%
Dec 31, 2025
American Century Investment Management, Inc.
4.92M
8.31%
-264.45K
-5.10%
Dec 31, 2025
Deerfield Management Company, L.P.
2.75M
4.65%
+131.61K
+5.02%
Dec 31, 2025
State Street Investment Management (US)
2.36M
3.99%
+31.80K
+1.37%
Dec 31, 2025
Jefferies LLC
2.35M
3.98%
+470.10K
+24.94%
Dec 31, 2025
Geode Capital Management, L.L.C.
1.41M
2.38%
-16.55K
-1.16%
Dec 31, 2025
View more

Related ETFs

Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
ETC 6 Meridian Small Cap Equity ETF
1.09%
State Street SPDR S&P Health Care Equipment ETF
0.85%
Lattice Hartford Multifactor Small Cap ETF
0.71%
Pacer US Small Cap Cash Cows Growth Leaders ETF
0.65%
Invesco S&P Spin-Off ETF
0.63%
Invesco NASDAQ Future Gen 200 ETF
0.49%
Invesco S&P SmallCap Health Care ETF
0.48%
Global X Aging Population ETF
0.31%
Royce Quant Small-Cap Quality Value ETF
0.29%
Inspire Small/Mid Cap ESG ETF
0.19%
View more
ETC 6 Meridian Small Cap Equity ETF
Proportion1.09%
State Street SPDR S&P Health Care Equipment ETF
Proportion0.85%
Lattice Hartford Multifactor Small Cap ETF
Proportion0.71%
Pacer US Small Cap Cash Cows Growth Leaders ETF
Proportion0.65%
Invesco S&P Spin-Off ETF
Proportion0.63%
Invesco NASDAQ Future Gen 200 ETF
Proportion0.49%
Invesco S&P SmallCap Health Care ETF
Proportion0.48%
Global X Aging Population ETF
Proportion0.31%
Royce Quant Small-Cap Quality Value ETF
Proportion0.29%
Inspire Small/Mid Cap ESG ETF
Proportion0.19%

Dividend

A total of 112.50M USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
May 05, 2026
EMBC.NB Interim Cash Dividend of gross USD 0.01 paid on Jun 15, 2026 going ex on May 28, 2026
May 28, 2026
Jun 15, 2026
May 28, 2026
Feb 05, 2026
EMBC.NB Interim Cash Dividend of gross USD 0.15 paid on Mar 17, 2026 going ex on Feb 27, 2026
Feb 27, 2026
Mar 17, 2026
Feb 27, 2026
Aug 08, 2025
EMBC.NB Interim Cash Dividend of gross USD 0.15 paid on Sep 15, 2025 going ex on Aug 29, 2025
Aug 29, 2025
Sep 15, 2025
Aug 29, 2025
May 09, 2025
EMBC.NB Interim Cash Dividend of gross USD 0.15 paid on Jun 13, 2025 going ex on May 28, 2025
May 28, 2025
Jun 13, 2025
May 28, 2025
Feb 06, 2025
EMBC.NB Interim Cash Dividend of gross USD 0.15 paid on Mar 14, 2025 going ex on Feb 28, 2025
Feb 28, 2025
Mar 14, 2025
Feb 28, 2025
Nov 26, 2024
EMBC.NB Final Cash Dividend of gross USD 0.15 paid on Dec 18, 2024 going ex on Dec 06, 2024
Dec 06, 2024
Dec 18, 2024
Dec 06, 2024
Aug 09, 2024
EMBC.NB Interim Cash Dividend of gross USD 0.15 paid on Sep 13, 2024 going ex on Aug 27, 2024
Aug 27, 2024
Sep 13, 2024
Aug 27, 2024
May 09, 2024
EMBC.NB Interim Cash Dividend of gross USD 0.15 paid on Jun 14, 2024 going ex on May 24, 2024
May 28, 2024
Jun 14, 2024
May 24, 2024
Feb 09, 2024
EMBC.NB Interim Cash Dividend of gross USD 0.15 paid on Mar 15, 2024 going ex on Feb 27, 2024
Feb 28, 2024
Mar 15, 2024
Feb 27, 2024
Nov 21, 2023
EMBC.NB Final Cash Dividend of gross USD 0.15 paid on Dec 15, 2023 going ex on Dec 01, 2023
Dec 04, 2023
Dec 15, 2023
Dec 01, 2023
View more

Stock Splits

Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
KeyAI